BioSpace News Archive

Research by Maastricht University proves for the first time that insect protein is as beneficial as the ‘gold standard’ milk protein; both have the same performance on digestion, absorption and on the ability to stimulate muscle production.

Reagents are critical raw materials in COVID-19 diagnostic kits. Local production secures Singapore’s goal to make testing part of the new normal, and mitigate disruptions from the international supply chain

SEL24, a first in class, orally available, dual PIM/FLT3 inhibitor, discovered and initially developed by Ryvu Therapeutics, then licensed out to - and currently developed by - the Menarini Group, is being evaluated in the DIAMOND-01 trial for the treatment of Acute Myeloid Leukemia

Accolade, Inc., the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences

Dexcom, Inc., a leader in real-time continuous glucose monitoring, announced that people with diabetes under the age of 18 living in Saskatchewan may now receive provincial coverage for the Dexcom G6 CGM System through Saskatchewan Health.

Second Sight Medical Products, Inc., a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced results of its annual meeting held May 28, 2021.

Life-long support with free-of-charge and proactive variant reclassification demonstrates unique commitment to improving the lives of patients with rare diseases

ZYESAMI™ is the First Investigational Medicine to Show Efficacy in a Randomized, Double-Blind, Multicenter Trial, Achieving More Instances of Recovery in Critically Ill COVID-19 Patients with Respiratory Failure, Compared to Placebo

This combination vaccine may simplify execution and reduce shots needed to complete CDC’s recommended child and adolescent immunization schedule

LifeStance Health Group, Inc., one of the nation’s largest providers of outpatient mental health care, announced it has launched the roadshow for the initial public offering of 40,000,000 shares of its common stock, with 32,800,000 shares being offered by the Company and 7,200,000 shares being offered by selling stockholders pursuant to a registration statement filed on Form S-1 with the Securities and Exchange Commission.